Concepedia

Mark Friedmann

MF

2

Publications

53

Citations

2

H-Index

2011

Active since

Affiliations

University of California, San Francisco(Current)

Thomas Cole Historic House

Mark Friedmann is an author at University of California, San Francisco specializing in cancer research, pharmacotherapy, and cancer therapeutics.

Top concepts

MedicineOncologyPharmacologyImmunotherapyCancer TherapyCancer ResearchPharmacotherapyOutcomes Research

Publications per year

2011–2012

2

Publications

2

Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for the treatment of previously untreated chronic lymphocytic leukemia

John Hornberger, Carolina Reyes, Ashwini Shewade et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2011 · 30 citations

Lifetime Horizon, Hematological Malignancy, Lymphoid Neoplasia +14

Cost-effectiveness of rituximab as maintenance therapy in patients with follicular non-Hodgkin lymphoma after responding to first-line rituximab plus chemotherapy

John Hornberger, R. Chien, Mark Friedmann et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2012 · 23 citations

Rows per page

1–2 of 2